3.5 mm Cypher Availability To Reduce Problems With Over-Expansion – Cordis

Johnson & Johnson/Cordis says it will meet U.S. hospitals' orders for the Cypher drug-eluting stent by the end of the year, when Boston Scientific's Taxus drug-eluting stent is expected to reach the U.S. market

More from Archive

More from Medtech Insight